The Diabetes Control and Complications Trial Re search Group.The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.N Engl J Med.1993; 329: 977–86.
2.
YuCC, WuM.S., WuC.H., YangC.W., HuangJ.Y., HongJ.J.Predialysis glycemic control is an independent predictor of clinical outcome in type II diabetics on continuous ambulatory peritoneal dialysis.Perit Dial Int.1997; 17: 262–8.
3.
KasiskeB.L., LakatuaJ.D., MaJ.Z., LouisT.A.A metaanalysis of the effects of dietary protein restriction on the rate of decline in renal function.Am J Kidney Dis.1998; 31: 954–61.
4.
JonesM.R.Etiology of severe malnutrition: Results of an international cross-sectional study in continuous ambulatory peritoneal dialysis patients.Am J Kidney Dis.1994; 23: 412–20.
5.
McCuskerF.X., TeehanB.P.Peritoneal dialysis: An evolving understanding.Semin Nephrol.1997; 17: 226–38.
6.
YoungG.A., KoppleJ.D., LindholmB., VoneshE.F., De VecchiA., ScalamognaA.Nutritional assessment of continuous ambulatory peritoneal dialysis patients: An international study.Am J Kidney Dis.1991; 17: 462–71.
7.
EspinosaA., Cueto-ManzanoA.M., Velazquez-AlvaC., HernandezA., CruzN., ZamoraB.Prevalence of malnutrition in Mexican CAPD diabetic and nondiabetic patients. In: KhannaR., ed. Advances in Peritoneal Dialysis.Toronto: Peritoneal Dialysis Publications, 1996; 12: 302–6.
8.
LindholmB., BergströmJ.Nutritional aspects on peritoneal dialysis.Kidney Int.1992; 12(Suppl 38): S165–71.
9.
TzamaloukasA.H., YuanZ.Y., BalaskasE., OreopoulosD.G.CAPD in end stage patients with renal disease due to diabetes mellitus -An update. In: KhannaR., NolphK.D., ProwantB.F., TwardowskiZ.J., OreopoulosD.G., eds. Advances in Peritoneal Dialysis.Toronto: Peritoneal Dialysis Bulletin, 1992; 8: 185–91.
EniaG., SicusoC., AlatiG., ZoccaliC.Subjective global assessment of nutrition in dialysis patients.Nephrol Dial Transplant.1993; 8: 1094–8.
12.
BaltzanM.A., ShokerA.A., BaltzanR.B., PylypchukG.B.Improved urea clearance raises the BUN in continuous peritoneal dialysis.Clin Nephrol.1996; 45: 183–7.
13.
TeehanB.P., SchleiferC.R., BrownJ.Adequacy of continuous ambulatory peritoneal dialysis: Morbidity and mortality in chronic peritoneal dialysis.Am J Kidney Dis.1994; 24: 990–1001.
14.
TeehanB.P., SchleiferC.R., BrownJ.M., SiglerM.H., RaimondoJ.Urea kinetic analysis and clinical outcome on CAPD: A five-year longitudinal study. In: KhannaR., NolphK.D., ProwantB.F., TwardowskiZ.J., OreopoulosD.G., eds. Advances in Peritoneal Dialysis.Toronto: Peritoneal Dialysis Bulletin, 1990; 6: 181–5.
15.
RoccoM.V., JordanJ.R., BurkartJ.M.The efficacy number as a predictor of morbidity and mortality in peritoneal dialysis patients.J Am Soc Nephrol.1993; 4: 1184–91.
16.
KeshaviahP.R., NolphK.D., MooreH.L., ProwantB., EmersonP.F., MeyerM.Lean body mass estimation by creatinine kinetics.J Am Soc Nephrol.1994; 4: 1475–85.
National Kidney Foundation Dialysis Outcomes Quality InitiativeClinical practice guidelines. IV. Assessment of nutritional status specifically as it relates to peritoneal dialysis.Am J Kidney Dis.1997; 30(Suppl 2): S83–5.
19.
LindholmB., BergströmJ.Nutritional requirements of peritoneal dialysis patients. In: GokalR., NolphK.D., eds. The Textbook of Peritoneal Dialysis.Dordrecht: Kluwer Academic Publishers; 1994: 443–72.
20.
KoppleJ.D., GrodsteinG.P., RobertsC.E., BlumenkrantzM.J.Nutritional status of the diabetic patient with chronic uremia. In: FriedmanE.A., L'EsperanceFAJr., eds. Diabetic Renal-Retinal Syndrome.Philadelphia: Grune & Stratton; 1980: 239–52.
21.
MillerD.G., LevineS., BistrianB., D'EllaJ.A.Diagnosis of protein calorie malnutrition in diabetic patients on hemodialysis and peritoneal dialysis.Nephron.1983; 33: 127–32.
22.
KredietR.T., ZuyderhoudtF.M.J., BoeschotenE.W., AriszL.Peritoneal permeability to proteins in diabetic and non-diabetic continuous ambulatory peritoneal dialysis patients.Nephron.1986; 42: 133–40.
23.
BrunnerF.P., BroyerM., BryngerH., ChallahS., DykesS.R., FassbinderW.Survival on renal replacement therapy: Data from the EDTA Registry.Nephrol Dial Transplant.1988; 2: 109–22.
24.
RottembourgJ., el ShahatY., AgrafiotisA., ThuillierY., de GrocF., JacobsC.CAPD in insulin dependent diabetic patients: a 40 month experience.Kidney Int.1983; 23: 40–5.
25.
McCuskerF.X., TeehanB.P., ThorpeK.E., KeshaviahP.R., ChurchillD.N. for the Canada-U.S.A. (CANUSA) Peritoneal Dialysis Study Group. How much peritoneal dialysis is required for the maintenance of a good nutritional state?Kidney Int.1996; 50(Suppl 56): S56–61.
26.
ChurchillN., TaylorW., KeshaviahR., ThorpeE., BeecroftL., JindalK.K.Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes.J Am Soc Nephrol.1996: 7: 198–207.
27.
LindsayR.M., SpannerE., HeidenheimP., LeFebvreJ.M., HodsmanA., BairdJ.Which comes first, Kt/V or PCR Chicken or egg?Kidney Int.1992; 42(Suppl 38): S32–6.
28.
KeshaviahP.Adequacy of CAPD: A quantitative approach.Kidney Int.1992; 38(Suppl): S160–4.
29.
BurkartJ.M., JordanJ., GarchowS., JonesM.Using a computer kinetic modeling program to prescribe PD.Perit Dial Int.1993; 13(Suppl 1): S77.
30.
United States Department of Health and Human Services, Public Health Service, National Institutes of Health.The USRDS Dialysis Morbidity and Mortality Study. USRDS 1997 Annual Data Report. Bethesda, MD: United States Renal Data System. 1997: 49–67.
31.
RothsteinR.D., AlaviA.The evaluation of the patient with gastroparesis secondary to insulin-dependent diabetes mellitus [Clinical conference].J Nucl Med.1992; 33: 1707–9.
32.
EisenbergB., MurataG.H., TzamaloukasA.H., ZagerP.G., AvasthiP.S.Gastroparesis in diabetics on chronic dialysis: Clinical and laboratory associations and predictive features.Nephron.1995; 70: 296–300.
TackJ., JanssensJ., VantrappenG., PeetersT., AnneseV., DepoortereI.Effect of erythromycin on gastric motility in controls and in diabetic gastroparesis.Gastroenterology.1992; 103: 72–9.
35.
BrownC.K., KhanderiaU.Use of metoclopramide, domperidone, and cisapride in the management of diabetic gastroparesis.Clin Pharm.1990; 9: 357–65.
36.
RossE.A., KooL.C.Improved nutrition after the detection and treatment of occult gastroparesis in nondiabetic dialysis patients.Am J Kidney Dis.1998; 31: 62–6.
37.
GallarP., OlietA., VigilA., OrtegaO., GuijoG.Gastroparesis: An important cause of hospitalization in continuous ambulatory peritoneal dialysis patients and the role of erythromycin.Perit Dial Int.1993; 13(Suppl 2): S183–6.
38.
JonesO.W., NidusB.D.Biotin and hiccups in chronic dialysis patients.J Renal Nutr.1991; 1: 80–3.
39.
HylanderB., BarkelingB., RossnerS.Eating behavior in continuous ambulatory peritoneal dialysis and hemodialysis patients.Am J Kidney Dis.1992; 20: 592–7.
40.
BoumaS.F., DwyerJ.T.Glucose absorption and weight change in 18 months of continuous ambulatory peritoneal dialysis.J Am Diet Assoc.1984; 84: 194–7.
41.
TzamaloukasA.H., MurataG.H., EisenbergB., MurphyG., AvasthiP.S.Hypoglycemia in diabetics on dialysis with poor glycemic control: Hemodialysis versus continuous ambulatory peritoneal dialysis.Int J Artif Organs.19927: 390–2.
42.
ScanzianiR., DozioB., BonforteG., SurianM.Nutritional parameters in diabetic patients on CAPD. In: KhannaR., ed. Advances in Peritoneal Dialysis.Toronto: Peritoneal Dialysis Publications, 1996; 12: 280–3.
43.
SpaiaS., ChristidouF., PangidisP., TsoulkasT., PazarloglouM., PappaA.Variability of peritoneal protein loss in diabetic and nondiabetic patients on continuous ambulatory peritoneal dialysis.Perit Dial Int.1993; 13(Suppl 2): S242–4.
44.
HartyJ.C., BoultonH., VenningM.C., GokalR.Is perito neal permeability an adverse risk factor for malnutrition in CAPD patients?Miner Electrolyte Metab.1996; 22: 13, 97–101.
45.
NolphK.D., MooreH.L., ProwantB., TwardowskiZ.J., KhannaR., GamboaS.Continuous ambulatory peritoneal dialysis with a high flux membrane.ASAIO J.1993; 39: 904–9.
46.
HeimbürgerO.Residual renal function, peritoneal transport characteristics and dialysis adequacy in peritoneal dialysis.Kidney Int.1996; 56(Suppl 56): S47–55.
47.
LambE.J., WorrallJ., BuhlerR., HarwoodS., Cat tellW.R., DawnayA.B.Effect of diabetes and peritonitis on the peritoneal equilibration test.Kidney Int.1995; 47: 1760–7.
48.
Food, and Agriculture Organization/World Health organizationEnergy and protein requirements. Report of a joint FAO/WHO ad hoc Expert Committee. Tech Rep Ser No 522. Geneva: World Health Organization; 1973.
49.
BergströmJ., FurstP., AlvestrandA., LindholmB.Protein and energy intake, nitrogen balance and nitrogen losses in patients treated with continuous ambulatory peritoneal dialysis.Kidney Int.1993; 44: 1048–57.
OldrizziL., RugiuC., MaschioG.Diet in chronic renal failure. In: MassryS.G., GlassockR.J., eds. Textbook of Nephrology. Vo12, 3rd ed.Baltimore, MD: Williams & Wilkins; 1995: 1504–12.
52.
KoppleJ.D., BernardD., MessanaJ., SwartzR., BergströmJ., LindholmB.Treatment of malnourished CAPD patients with an amino acid based dialysate.Kidney Int.1995; 47: 1148–57.
53.
FouqueD.Causes and interventions for malnutrition in patients undergoing maintenance dialysis.Blood Purif.1997; 15: 112–20.
54.
ZieglerT.R., LazarusJ.M., YoungL.S., HakimR., WilmoreD.W.Effects of recombinant human growth hormone in adults receiving maintenance hemodialysis.J Am Soc Nephrol.1991; 2: 1130–5.
55.
IkizierT.A., WingardR.L., BreyersJ.A., SchulmanG., ParkerR.A.Short-term effects of recombinant human growth hormone in CAPD patients.Kidney Int.1994; 46: 1178–83.